On August 14, 2025, Dalian Bio-Chem Co., Ltd. received the decision from the Dalian Securities Regulatory Bureau regarding the imposition of corrective measures on Dalian Bio-Chem Co., Ltd. and the issuance of warning letters to Liu Xianwu and Wang Xiliang. Upon investigation, it was found that the company had issues in internal control regarding fund management, procurement management, and contract management, with the company's chairman Liu Xianwu and CFO Wang Xiliang bearing primary responsibility. The regulatory bureau decided to order the company to make corrections, issue warning letters to the two individuals, and record this in their integrity files